Gan & Lee Pharmaceuticals Co Ltd (603087)

Currency in CNY
62.50
+0.46(+0.74%)
Closed·
603087 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
603087 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
61.7362.99
52 wk Range
37.6365.90
Key Statistics
Bid/Ask
62.50 / 62.51
Prev. Close
62.5
Open
61.92
Day's Range
61.73-62.99
52 wk Range
37.63-65.9
Volume
12.43M
Average Volume (3m)
14.93M
1-Year Change
45.25%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603087 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
66.00
Upside
+5.60%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Gan & Lee Pharmaceuticals Co Ltd Company Profile

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company’s products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People’s Republic of China.

Employees
5245
Market
China

Compare 603087 to Peers and Sector

Metrics to compare
603087
Peers
Sector
Relationship
P/E Ratio
40.7x37.7x−0.5x
PEG Ratio
0.52−1.150.00
Price/Book
3.4x2.1x2.6x
Price / LTM Sales
9.9x7.4x3.3x
Upside (Analyst Target)
5.6%0.3%40.1%
Fair Value Upside
Unlock8.2%5.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 66.00
(+5.60% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.55%
Dividend Yield
2.40%
Industry Median 1.50%
Annualised payout
1.50
Paid annually
5-Years Growth
+33.25%
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
0.49 / 0.39
Revenue / Forecast
1.08B / 1.11B
EPS Revisions
Last 90 days

603087 Income Statement

FAQ

What Stock Exchange Does Gan Lee Pharmaceuticals Trade On?

Gan Lee Pharmaceuticals is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Gan Lee Pharmaceuticals?

The stock symbol for Gan Lee Pharmaceuticals is "603087."

What Is the Gan Lee Pharmaceuticals Market Cap?

As of today, Gan Lee Pharmaceuticals market cap is 37.44B.

What Is Gan Lee Pharmaceuticals's Earnings Per Share (TTM)?

The Gan Lee Pharmaceuticals EPS (TTM) is 1.55.

When Is the Next Gan Lee Pharmaceuticals Earnings Date?

Gan Lee Pharmaceuticals will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is 603087 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Gan Lee Pharmaceuticals Stock Split?

Gan Lee Pharmaceuticals has split 1 times.

How Many Employees Does Gan Lee Pharmaceuticals Have?

Gan Lee Pharmaceuticals has 5245 employees.

What is the current trading status of Gan Lee Pharmaceuticals (603087)?

As of 17 Aug 2025, Gan Lee Pharmaceuticals (603087) is trading at a price of 62.50, with a previous close of 62.50. The stock has fluctuated within a day range of 61.73 to 62.99, while its 52-week range spans from 37.63 to 65.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.